Recent Articles
- MFN one year on: Taking stock of US drug pricing reform
- Comparative effectiveness: Queries and clarifications
- Prevalence of Obesity and Related Conditions and GLP-1 Use in Medicare Fee-for-Service Beneficiaries
- Genesis launches free access to EVID AI, its full-spectrum evidence synthesis platform, through 2026
- Genesis Research Group invites colleagues to visit their booth at ISPOR 2026 and explore their work




